| Update on hepatitis E virology: Implications for clinical practice Y Debing, D Moradpour, J Neyts, J Gouttenoire Journal of hepatology 65 (1), 200-212, 2016 | 229 | 2016 |
| Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin VLD Thi, Y Debing, X Wu, CM Rice, J Neyts, D Moradpour, J Gouttenoire Gastroenterology 150 (1), 82-85. e4, 2016 | 222 | 2016 |
| A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients Y Debing, A Gisa, K Dallmeier, S Pischke, B Bremer, M Manns, ... Gastroenterology 147 (5), 1008-1011. e7, 2014 | 212 | 2014 |
| Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus Y Wang, X Zhou, Y Debing, K Chen, LJW Van Der Laan, J Neyts, ... Gastroenterology 146 (7), 1775-1783, 2014 | 198 | 2014 |
| Ribavirin Inhibits In Vitro Hepatitis E Virus Replication through Depletion of Cellular GTP Pools and Is Moderately Synergistic with Alpha Interferon Y Debing, SU Emerson, Y Wang, Q Pan, J Balzarini, K Dallmeier, J Neyts Antimicrobial agents and chemotherapy 58 (1), 267-273, 2014 | 158 | 2014 |
| Viral macro domains reverse protein ADP-ribosylation C Li, Y Debing, G Jankevicius, J Neyts, I Ahel, B Coutard, B Canard Journal of virology 90 (19), 8478-8486, 2016 | 153 | 2016 |
| Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature J Verdonschot, M Hazebroek, J Merken, Y Debing, R Dennert, ... European journal of heart failure 18 (12), 1430-1441, 2016 | 150 | 2016 |
| Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity Y Debing, C Ramière, K Dallmeier, G Piorkowski, MA Trabaud, F Lebossé, ... Journal of hepatology 65 (3), 499-508, 2016 | 132 | 2016 |
| Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver IM Sayed, L Verhoye, L Cocquerel, F Abravanel, L Foquet, C Montpellier, ... Gut 66 (5), 920-929, 2017 | 130 | 2017 |
| Extra‐hepatic replication and infection of hepatitis E virus in neuronal‐derived cells SA Drave, Y Debing, S Walter, D Todt, M Engelmann, M Friesland, ... Journal of viral hepatitis 23 (7), 512-521, 2016 | 119 | 2016 |
| The Viral Polymerase Inhibitor 2′-C-Methylcytidine Inhibits Norwalk Virus Replication and Protects against Norovirus-Induced Diarrhea and Mortality in a Mouse … J Rocha-Pereira, D Jochmans, Y Debing, E Verbeken, MSJ Nascimento, ... Journal of virology 87 (21), 11798-11805, 2013 | 110 | 2013 |
| The future of antivirals: broad-spectrum inhibitors Y Debing, J Neyts, L Delang Current opinion in infectious diseases 28 (6), 596-602, 2015 | 81 | 2015 |
| Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication N Helsen, Y Debing, J Paeshuyse, K Dallmeier, R Boon, M Coll, ... Journal of Hepatology 64 (3), 565-573, 2016 | 59 | 2016 |
| Antiviral strategies for hepatitis E virus Y Debing, J Neyts Antiviral research 102, 106-118, 2014 | 59 | 2014 |
| Intervention strategies for emerging viruses: use of antivirals Y Debing, D Jochmans, J Neyts Current opinion in virology 3 (2), 217-224, 2013 | 46 | 2013 |
| Hepatitis E virus replication and interferon responses in human placental cells L Knegendorf, SA Drave, VL Dao Thi, Y Debing, RJP Brown, ... Hepatology communications 2 (2), 173-187, 2018 | 43 | 2018 |
| Molecular biology and inhibitors of hepatitis A virus Y Debing, J Neyts, HJ Thibaut Medicinal research reviews 34 (5), 895-917, 2014 | 41 | 2014 |
| A rat model for hepatitis E virus Y Debing, N Mishra, E Verbeken, K Ramaekers, K Dallmeier, J Neyts Disease models & mechanisms 9 (10), 1203-1210, 2016 | 40 | 2016 |
| Capsid assembly modulators as antiviral agents against HBV: molecular mechanisms and clinical perspectives V Taverniti, G Ligat, Y Debing, DB Kum, TF Baumert, ER Verrier Journal of clinical medicine 11 (5), 1349, 2022 | 38 | 2022 |
| 3′, 5′ Di-O-trityluridine inhibits in vitro flavivirus replication T De Burghgraeve, B Selisko, S Kaptein, G Chatelain, P Leyssen, ... Antiviral research 98 (2), 242-247, 2013 | 31 | 2013 |
